ALBANY, New York, March 15, 2018 /PRNewswire/ --
The global healthcare contract research outsourcing market wasvalued at US$ 30.0 Bn in 2016 and is projected to expand at a cumulative annual growth rate (CAGR) of 6.8% from 2017 to 2025 according to a new report published by Transparency Market Research (TMR) titled "Healthcare Contract Research Outsourcing Market Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2017
Get PDF Brochure for Research Insights at https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=800
Complex Regulatory and Growing Regulatory Burden to Fuel Market Growth
The global healthcare contract research outsourcing is projected to be potentially driven by the growing complexity of the regulatory procedures and increasing intervention of the healthcare providers in the drug approval and reimbursement process. The therapeutic expertise and varied regional filing process expertise offered by CROs is further fueling the healthcare contract research outsourcing market. The contract research organizations provides wide range of services and solutions to support regulatory filing at various stages of drug development process. These services and business solutions offered by the CROs help the healthcare companies to complete simultaneous regulatory submissions in different regions efficiently and effectively. The key players offering the healthcare contract research outsourcing are coming up with the strategic solutions for long term partnership supporting the healthcare companies at various stages of drug development, thereby reducing the overall development cost and thus, improving the cost effectiveness and efficiency of drug development process. Companies are focusing on the expansion of commercial services so as to effectively support the complete product lifecycle
Request a Custom Report at https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=800
Regulatory Services in Healthcare Contract Research Outsourcing is Projected to be Highly Lucrative Segment
Clinical trials are most common outsourced services by the healthcare companies. Due to the globalization of the clinical trials and the lack of therapeutic expertise in the for new drug development in unexplored niche market. However the outsourcing of regulatory services is growing due to the increased stringency of the regulatory bodies, complex regulatory process and changing regulatory requirements according to the region.
Oncology/Hematology segment in Healthcare Contract Research Outsourcing Leads the Market
The report offers the detailed segmentation by therapeutic area of healthcare contract research outsourcing into oncology/hematology, CNS, CV/metabolic, respiratory, infectious diseases, immunology, rare diseases, medical devices and others. The oncology/hematology therapeutic segment is poised to account for leading share of the market during the forecast period 2017-2025. The factors attributed to higher share of oncology/hematology therapeutic segment includes huge unmet treatment needs, robust product pipeline, increased competition and increasing incidence of oncology. The various benefits available with outsourcing of oncology/hematology related services has led to key share of the segment in global market.
Request For Discount On This Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=800
Pharmaceutical companies dominates the market and the segment is estimated to witness highest CAGR during the forecast period.
Among the end-user, the pharmaceutical companies accounted for leading share in global healthcare contract research outsourcing market and is estimated to grow with a CAGR more than 6% during the forecast period. Rise in complexity in drug development, need for reduced drug development timelines, cost effectiveness and the advantage of gaining therapeutic expertise along with outsourcing services has favored outsourcing services to the CROs has led to prominent share of pharmaceutical companies segment in the global healthcare CRO market. Development in the field of genetics, elaborate laboratory requirements, changing clinical trial environment, and requirement for detailed study data is likely to drive the expansion of biotechnology companies' segment growth during the forecast period.
Asia Pacific region represents potential business development opportunity.
The North America and Europe region accounted for key share of global healthcare contract research outsourcing market in 2016. The presence of world renowned research expertise in CNS, rare disease, oncology, immunology, and stem cells and advanced infrastructure of clinical research sites have contributed to leading share of these region in the global healthcare CRO market. Asia Pacific is projected to be the most attractive market for healthcare contract research outsourcing, with highest attractiveness index. The market in the Asia Pacific region is projected expand at high CAGR of over 8% during the forecast period due to the large patient population in the emerging countries like India and China, well established data integrity regulations and high digital healthcare IT budgets in the countries like Japan, Taiwan, South Korea Malaysia, Singapore etc. Market in Latin America is poised to grow at moderate growth rate during the forecast period.
Request Sample of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=800
Key trend of acquisition and collaboration among the leading players to expand the services and increase geographic presence has been observed in last few years.
The report also provide profiles of leading players operating in global healthcare contract research outsourcing market. Syneos Health, IQVIA, PRA Health Sciences, Inc., ICON PLC, and Laboratory Corporation of America Holdings etc. are some of the leading players operating in the global healthcare contract research outsourcing market accounting for significant market share. Companies operating in the CRO industry are aiming to expand their service offerings and increase their geographic presence by means of strategic acquisition and collaboration with leading players in respective domains and geography. In January 2017, INC Research Holdings, Inc. merged with inVentiv Health, Inc. expanding its business offerings in phase I-IV services. Other prominent players operating in the global healthcare contract research outsourcing include market PAREXEL International, Charles River, Medpace and Pharmaceutical Product Development, LLC.
Popular Research Reports by TMR:
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company's exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR's experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
TMR's data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.
Transparency Market Research State Tower, 90 State Street, Suite 700, Albany NY - 12207 United States
Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: email@example.com Website: http://www.transparencymarketresearch.com
Research Blog: https://theglobalhealthnews.com/
SOURCE Transparency Market Research
Subscribe to our Free Newsletters!
Pneumonitis usually refers to inflammation of lung tissue due to various non-infective causes such ...
Fremanezumab-vfrm is used as a preventive treatment for a migraine headache in adult patients. It ...
DOOR syndrome is a rare genetic disorder marked by deafness, short or absent fingernails, abnormal ...View All